Beyond Air (NASDAQ:XAIR) Receives Buy Rating from D. Boral Capital

D. Boral Capital reiterated their buy rating on shares of Beyond Air (NASDAQ:XAIR) in a research note issued to investors on Wednesday morning,Benzinga reports. D. Boral Capital currently has a $11.00 target price on the stock.

Several other equities analysts also recently issued reports on the stock. Weiss Ratings reaffirmed a “sell (e)” rating on shares of Beyond Air in a research note on Monday, December 22nd. Rodman & Renshaw started coverage on Beyond Air in a report on Tuesday. They issued a “buy” rating for the company. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $11.00.

Beyond Air Stock Performance

NASDAQ:XAIR opened at $1.82 on Wednesday. The stock has a market cap of $14.58 million, a P/E ratio of -0.24 and a beta of 0.34. The company has a current ratio of 4.24, a quick ratio of 3.73 and a debt-to-equity ratio of 0.77. The stock’s 50-day moving average is $1.16 and its 200-day moving average is $2.07. Beyond Air has a 1-year low of $0.67 and a 1-year high of $10.40.

Beyond Air (NASDAQ:XAIR) last issued its quarterly earnings data on Monday, November 10th. The company reported ($1.25) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.10) by ($0.15). Beyond Air had a negative net margin of 632.51% and a negative return on equity of 261.08%. The business had revenue of $1.82 million during the quarter, compared to the consensus estimate of $2.54 million. Equities research analysts anticipate that Beyond Air will post -0.79 earnings per share for the current year.

Institutional Trading of Beyond Air

A number of large investors have recently bought and sold shares of the business. Wealth Effects LLC raised its position in shares of Beyond Air by 42.5% in the 2nd quarter. Wealth Effects LLC now owns 278,100 shares of the company’s stock worth $48,000 after acquiring an additional 83,000 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Beyond Air by 1.5% during the 2nd quarter. Geode Capital Management LLC now owns 838,319 shares of the company’s stock valued at $144,000 after purchasing an additional 12,598 shares in the last quarter. Osaic Holdings Inc. grew its stake in Beyond Air by 26.4% during the second quarter. Osaic Holdings Inc. now owns 162,560 shares of the company’s stock worth $29,000 after purchasing an additional 34,000 shares during the period. Virtu Financial LLC bought a new stake in Beyond Air in the third quarter worth approximately $48,000. Finally, Alyeska Investment Group L.P. bought a new stake in Beyond Air in the third quarter worth approximately $1,753,000. 31.50% of the stock is currently owned by institutional investors and hedge funds.

Beyond Air Company Profile

Beyond Air, Inc is a clinical-stage medical technology company focused on the development and commercialization of inhaled nitric oxide (NO) therapy for pulmonary and respiratory diseases. The company’s proprietary LungFit® platform delivers pulsed, low-dose nitric oxide gas through compact, portable devices designed to support treatments in both inpatient and outpatient settings. Beyond Air’s approach leverages NO’s antimicrobial, vasodilatory and anti-inflammatory properties to address a range of unmet needs in respiratory medicine.

The company’s lead candidate, LungFit® PH, is under investigation for the treatment of pulmonary hypertension, with ongoing clinical studies assessing its impact on pulmonary arterial pressure and exercise capacity.